Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 1/2002

01-03-2002 | Article

Down regulation of Bc12 expression in invasive ductal carcinomas is both estrogen- and progesterone-receptor dependent and associated with poor prognostic factors

Authors: Sung-Hye Park, Hanseong Kim, Byung-Joo Song

Published in: Pathology & Oncology Research | Issue 1/2002

Login to get access
Metadata
Title
Down regulation of Bc12 expression in invasive ductal carcinomas is both estrogen- and progesterone-receptor dependent and associated with poor prognostic factors
Authors
Sung-Hye Park
Hanseong Kim
Byung-Joo Song
Publication date
01-03-2002
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2002
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF03033697

Other articles of this Issue 1/2002

Pathology & Oncology Research 1/2002 Go to the issue

Article

CD44 variant exons in leukemia and lymphoma

Article

Results of ovary tumor treatment with abdominally administered198Au evaluated on the basis of long term follow up

Article

Kaposi’s sarcoma: Clinico-pathological analysis of human immunodeficiency virus (HIV) and non-HIV associated cases

Article

Effect of sulfated β-cyclodextrin, a water soluble cycloamylose, on the promotion and/or inhibition of angiogenesis

Article

Large-Scale pathology-based cancer data - a reflection of population-based cancer data

Article

HLA-DQB1 alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits